 
                                Avi Roy
@agingroy
Biomed Scientist in #longevity. Mentor & Investor in Health startups. Past CTO @BioVivaScience ,Researcher @CASMIORG ,Lead @oxfordscisoc @NewsInLongevity ,BGRF
ID: 14637833
http://uda.com/ 03-05-2008 13:45:12
6,6K Tweet
2,2K Followers
2,2K Following
 
         
         
         
         
         
         
         
        The modern cardiovascular drug development landscape has been largely shaped by human genetic studies. Emerging IL-6 targeting therapies are a landmark example. In this Circulation: Genomic and Precision Medicine paper with the Tourmaline Bio team (developing an anti-IL6 antibody for atherosclerotic
 
                        
                    
                    
                    
                 
         
         
         
         
         
         
         
                         
                         
                         
                         
                         
                         
                         
                        